Mr. Evans has over 15 years of experience leading public and private life science companies through financial operations, investor relations, and business development activities.
Prior to joining Rezolute, he served as Chief Executive Officer of AlloRock, Inc., a biotechnology company in the cardiometabolic disease space, as well as Chief Executive Officer of Specialty Renal Products, Inc., a medical device company in the dialysis space. Previously, Mr. Evans served as Chief Executive Officer of Nephros, Inc. (Nasdaq:NEPH), and Chief Financial Officer of Nile Therapeutics, Inc. (Nasdaq:NLTX). Since 2015, Mr. Evans has been Managing Director of PoC Capital, LLC, a fund focused on investing in public life science companies.
He holds a Bachelor of Science in Chemical Engineering from Rice University, a Master of Science in Biomedical Engineering from a joint program at the University of Texas at Arlington and Southwestern Medical School, and a Master of Business Administration from the Fuqua School of Business at Duke University.
What is Daron Evans' net worth?
The estimated net worth of Daron Evans is at least $2.61 million as of June 24th, 2025. Evans owns 268,900 shares of Rezolute stock worth more than $2,608,330 as of December 5th. This net worth evaluation does not reflect any other assets that Evans may own. Learn More about Daron Evans' net worth.
How old is Daron Evans?
Evans is currently 50 years old. There are 2 older executives and no younger executives at Rezolute. The oldest executive at Rezolute is Mr. Nevan Charles Elam J.D., Founder, CEO & Acting Chairman of the Board, who is 57 years old. Learn More on Daron Evans' age.
How do I contact Daron Evans?
Has Daron Evans been buying or selling shares of Rezolute?
Daron Evans has not been actively trading shares of Rezolute during the last ninety days. Most recently, on Tuesday, June 24th, Daron Evans bought 5,000 shares of Rezolute stock. The stock was acquired at an average cost of $4.05 per share, with a total value of $20,250.00. Following the completion of the transaction, the chief financial officer now directly owns 268,900 shares of the company's stock, valued at $1,089,045. Learn More on Daron Evans' trading history.
Who are Rezolute's active insiders?
Are insiders buying or selling shares of Rezolute?
During the last twelve months, Rezolute insiders bought shares 10 times. They purchased a total of 1,299,405 shares worth more than $4,256,190.31. The most recent insider tranaction occured on June, 25th when insider Brian Kenneth Roberts bought 2,500 shares worth more than $10,950.00. Insiders at Rezolute own 14.8% of the company.
Learn More about insider trades at Rezolute. Information on this page was last updated on 6/25/2025.
